Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.

PloS one - 1 Jan 2017

Takamochi Kazuya, Mogushi Kaoru, Kawaji Hideya, Imashimizu Kota, Fukui Mariko, Oh Shiaki, Itoh Masayoshi, Hayashizaki Yoshihide, Ko Weijey, Akeboshi Masao, Suzuki Kenji

Abstract excerpt

BACKGROUND: 18F-fluoro-2-deoxy-glucose (18F-FDG) positron emission tomography (PET) is a functional imaging modality based on glucose metabolism. The correlation between EGFR or KRAS mutation status and the standardized uptake value (SUV) of 18F-FDG PET scanning has not been fully elucidated. METHODS: Correlations between EGFR or KRAS mutation status and clinicopathological factors including SUVmax were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Biological Transport

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorodeoxyglucose F18

Share to Positron-Emission Tomography

Share to Proto-Oncogene Proteins p21(ras)

Share to Radiopharmaceuticals

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 28422979
DOI: 10.1371/journal.pone.0175622
PMCID: PMC5396974

Genes

EGFR
KRAS
ANLN
CIT
GAPDH
GPI
KPNA2
PTTG1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.PMID 28422979Read ↗

Expression of FAP in Lung Cancer and Its Correlation With the Tumor Glucose Metabolism and the HistopathologySemantic proximity Read ↗

Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer.Semantic proximity Read ↗

Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma.Semantic proximity Read ↗

Association between metabolic activity and molecular alterations in lung adenocarcinoma: Insights from 18F-FDG PET/CT.Semantic proximity Read ↗

Value of ¹⁸F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma.Semantic proximity Read ↗

Relation of EGFR Mutation Status to Metabolic Activity in Localized Lung Adenocarcinoma and Its Influence on the Use of FDG PET/CT Parameters in Prognosis.Semantic proximity Read ↗

Correlation of FDG PET/CT, tumor markers and Ki-67 index with EGFR mutation or positive ALK expression in patients with non-small cell lung cancer.Semantic proximity Read ↗

Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS.Semantic proximity Read ↗

Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes.Semantic proximity Read ↗

KRASG12C Can Either Promote or Impair Cap-Dependent Translation in Two Different Lung Adenocarcinoma Cell Lines.Semantic proximity Read ↗

Primary metabolic tumor volume from 18F-FDG PET/CT associated with epidermal growth factor receptor mutation in lung adenocarcinoma patients.Semantic proximity Read ↗

FDG uptake in non-small cell lung cancer is not an independent predictor of EGFR or KRAS mutation status: a retrospective analysis of 206 patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.